Tagged With EpiPen

Ten years ago, I testified before Congress about drug pricing — and it's only gotten worse. Here's what's wrong, and how we may be able to fix it.

Jasmin Weaver

Mylan tumbles on reported shortages of its life-saving EpiPens

Daniel Strauss

Dispensed: Complaints of broken EpiPens, what pharma thinks of Amazon, and research-less unicorns

Lydia Ramsey

People rely on the EpiPen in life-or-death situations, but the devices are remarkably hard to test. Here’s why.

Emma Court

EpiPens weren’t working. It took 3 years and the FDA stepping in before serious change — with potentially deadly outcomes

Emma Court

Drug giant Novartis is gearing up to release a cheaper EpiPen rival, but one big factor may make competition tricky

Emma Court

Mylan stock dropped 7% after second quarter sales slumped

Charlotte Hu

There's a shortage of EpiPens in the US

Lydia Ramsey

Advisers are telling investors to go scorched earth on the company that makes EpiPen

Linette Lopez

It sounds like the maker of EpiPen is freaking out ahead of a big shareholder meeting

Linette Lopez

The chairman of the company behind the EpiPen reportedly flipped everyone off when they asked about drug pricing

Lydia Ramsey

The chairman of the company behind the EpiPen made $98 million in 2016

Lydia Ramsey

Mylan is recalling EpiPens in the US

Lydia Ramsey

The EpiPen just got some more competition -- but there's a catch

Lydia Ramsey

The EpiPen maker's CEO totally backs Trump on drug prices -- except for how he plans to lower them

Lydia Ramsey

The $300 generic EpiPen is here

Lydia Ramsey

Mylan says it won't testify at a Senate hearing about the EpiPen

Lydia Ramsey

Mylan and the DOJ can't seem to get on the same page these days

Lydia Ramsey

Investigations are piling up at Mylan

Lydia Ramsey

Outrage over the price of the EpiPen actually led to more prescriptions for the device

Lydia Ramsey